Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2018 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Achieved strong third quarter financial performance and increased full year 2018 guidance Acquired AMAG-423 for severe preeclampsia, reaffirming the company's focus on...
October 25, 2018 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, November 1, 2018 at 8:00 a.m. ET

WALTHAM, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its third quarter 2018 financial results will be released on Thursday, November 1,...
October 04, 2018 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals and Endoceutics Announce Presentation at the 2018 Annual Meeting of The North American Menopause Society on the Effect of Time Since Menopause, Age and Previous Hormone Therapy on the Response to Intravaginal Prasterone

Study Suggests that While All Postmenopausal Women Benefit from Treatment with Prasterone (INTRAROSA®), Women Experience Greatest Relief of Moderate to Severe Dyspareunia when started on INTRAROSA®...
September 26, 2018 06:30 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia

Currently no FDA-approved treatment options for severe preeclampsia, a leading cause of maternal and neonatal mortality Acquisition expands AMAG’s maternal health portfolio and commitment to...
September 20, 2018 09:15 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Partners With Emmy-Nominated Actress Cheryl Hines and Dr. Marla Shapiro to Start a Conversation About an Often Unrecognized and Untreated Medical Condition, Painful Sex Due to Menopause

WALTHAM, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that together with Emmy®-nominated actress Cheryl Hines and leading family medicine and...
September 06, 2018 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Pays Off $475 Million of Senior Secured Notes

WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has redeemed $475 million of its outstanding 7.875% senior notes, using the...
August 23, 2018 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences: B. Riley...
August 06, 2018 16:30 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Completes Divestiture of Cord Blood Registry®

WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it has closed the previously announced divestiture of Cord Blood Registry (CBR®) to GI...
August 06, 2018 07:30 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs

WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Brian Robinson, M.D. as senior vice president, medical affairs,...
August 02, 2018 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Achieved 12% revenue growth and record quarterly sales Raising full year revenue and adjusted EBITDA guidance for pharmaceutical products Conference call scheduled for 8:00 a.m. ET today ...